Site icon Herbsjoy.com

Apollo Cancer Center introduces blood test for early diagnosis of breast cancer

In the first place, blood tests can detect breast cancer in the early stages. It was launched in India on Wednesday and was available by Datas Cancer Genetics, a private company that has partnered with the Apollo Group of Hospitals. According to the report, blood tests can help detect breast cancer in the early stages for those aged over 40 years. This is an innovative diagnostic technique that has been adopted by 15 countries including several countries in Europe.

According to the expert team, this blood test has 99 percent accuracy. “Because the case of cancer continues to be reported in India, the cost of treatment or treatment for patient management is the main cause of concern. The only way that is the way with it we can withdraw (the cost of treatment) is to detect the patient in the early stages. If a woman is detected at the stage Early breast cancer, they can be treated effectively, which leads to an increase in life expectancy and reducing treatment of treatment.The blood test was approved by the World Health Organization (WHO) and the administration of the US food and drugs in November last year after seeing the benefits during the biggest clinical trial. The doctor said, “This gives the biggest clinical test that has been submitted to WHO. In this special test, data is collected in breast cancer where more than 8,000 women without symptoms are filtered and followed up for a period of 12 months. The study is also available on our website . “

This study has shown cases of stage 0 and stage 1 breast cancer detected with 99 percent accuracy. The test, labeled as Easycheck’s breasts, will cost RS 6,000. It was approved by the administration of US food and drugs in November last year and was indicated as an annual test for healthy women over the age of 40 who might not have symptoms. This technology claims to have a sensitivity of almost 99 percent, which means it has less than 1 percent of false positive reports, with more than 88 percent of specificity, which means that in about 22 percent of cases there is a possibility of fake negativity though.
“This is not a replacement of mammograms but women who are tested positive for breast cancer using new technology can conduct conventional screening examinations and can be directly used for biopsy and plan their care for cancer,” said Dr. Ramesh Sarin, a senior surgical oncologist with Apollo Hospital in Delhi . The doctor further suggested that if a woman was a negative test, then she also had to do another screening test to put aside the cancer completely.

“This is the first time in India that Apollo is centered in relation to genetic flat cancer carrying this non-invasive blood test where it can detect breast cancer in the early stages of individuals without symptoms with high accuracy. This will help us save lives and preserve quality Live, “said Sangeetha Reddy, JMD, Apollo Hospitals.

Exit mobile version